Novavax, Inc. (NVAX)
USD 6.17
(-1.12%)
USD 6.17
(-1.12%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -545.06 Million USD | 17.16% |
| 2022 | -657.93 Million USD | 62.27% |
| 2021 | -1.74 Billion USD | -307.89% |
| 2020 | -427.5 Million USD | -228.59% |
| 2019 | -130.1 Million USD | 29.58% |
| 2018 | -184.74 Million USD | -0.53% |
| 2017 | -183.76 Million USD | 34.36% |
| 2016 | -279.96 Million USD | -78.39% |
| 2015 | -156.93 Million USD | -89.2% |
| 2014 | -82.94 Million USD | -59.57% |
| 2013 | -51.98 Million USD | -82.35% |
| 2012 | -28.5 Million USD | -47.22% |
| 2011 | -19.36 Million USD | 45.77% |
| 2010 | -35.7 Million USD | 6.95% |
| 2009 | -38.37 Million USD | -6.45% |
| 2008 | -36.04 Million USD | -3.69% |
| 2007 | -34.76 Million USD | -50.71% |
| 2006 | -23.06 Million USD | -106.44% |
| 2005 | -11.17 Million USD | 56.89% |
| 2004 | -25.92 Million USD | -50.06% |
| 2003 | -17.27 Million USD | 23.9% |
| 2002 | -22.69 Million USD | -132.91% |
| 2001 | -9.74 Million USD | 20.06% |
| 2000 | -12.19 Million USD | -170.91% |
| 1999 | -4.5 Million USD | 6.25% |
| 1998 | -4.8 Million USD | -6.67% |
| 1997 | -4.5 Million USD | 18.18% |
| 1996 | -5.5 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 162.38 Million USD | 210.05% |
| 2024 Q1 | -147.55 Million USD | 17.29% |
| 2023 FY | -545.06 Million USD | 17.16% |
| 2023 Q3 | -130.77 Million USD | -325.44% |
| 2023 Q2 | 58 Million USD | 119.74% |
| 2023 Q1 | -293.9 Million USD | -61.27% |
| 2023 Q4 | -178.38 Million USD | -36.41% |
| 2022 Q3 | -168.61 Million USD | 66.97% |
| 2022 Q4 | -182.24 Million USD | -8.09% |
| 2022 Q1 | 203.4 Million USD | 124.04% |
| 2022 FY | -657.93 Million USD | 62.27% |
| 2022 Q2 | -510.48 Million USD | -350.97% |
| 2021 FY | -1.74 Billion USD | -307.89% |
| 2021 Q2 | -352.31 Million USD | -58.19% |
| 2021 Q1 | -222.71 Million USD | -25.43% |
| 2021 Q3 | -322.43 Million USD | 8.48% |
| 2021 Q4 | -846.28 Million USD | -162.47% |
| 2020 Q3 | -197.31 Million USD | -1026.13% |
| 2020 Q2 | -17.52 Million USD | 32.26% |
| 2020 FY | -427.5 Million USD | -228.59% |
| 2020 Q1 | -25.86 Million USD | 18.74% |
| 2020 Q4 | -177.56 Million USD | 10.01% |
| 2019 Q4 | -31.83 Million USD | -76.41% |
| 2019 FY | -130.1 Million USD | 29.58% |
| 2019 Q3 | -18.04 Million USD | 54.44% |
| 2019 Q1 | -43.21 Million USD | 12.4% |
| 2019 Q2 | -39.6 Million USD | 8.36% |
| 2018 Q1 | -46.35 Million USD | 8.83% |
| 2018 FY | -184.74 Million USD | -0.53% |
| 2018 Q3 | -44.57 Million USD | -0.18% |
| 2018 Q2 | -44.49 Million USD | 4.01% |
| 2018 Q4 | -49.33 Million USD | -10.69% |
| 2017 FY | -183.76 Million USD | 34.36% |
| 2017 Q2 | -44.46 Million USD | -1.39% |
| 2017 Q3 | -44.6 Million USD | -0.32% |
| 2017 Q4 | -50.84 Million USD | -13.98% |
| 2017 Q1 | -43.85 Million USD | 23.21% |
| 2016 Q3 | -66.25 Million USD | 16.51% |
| 2016 FY | -279.96 Million USD | -78.39% |
| 2016 Q2 | -79.35 Million USD | -2.72% |
| 2016 Q4 | -57.1 Million USD | 13.8% |
| 2016 Q1 | -77.25 Million USD | 1.97% |
| 2015 Q3 | -33.12 Million USD | -60.46% |
| 2015 Q4 | -78.8 Million USD | -137.94% |
| 2015 Q2 | -20.64 Million USD | 15.3% |
| 2015 Q1 | -24.37 Million USD | 22.75% |
| 2015 FY | -156.93 Million USD | -89.2% |
| 2014 Q3 | -19.72 Million USD | -10.43% |
| 2014 FY | -82.94 Million USD | -59.57% |
| 2014 Q2 | -17.86 Million USD | -29.36% |
| 2014 Q1 | -13.81 Million USD | 1.74% |
| 2014 Q4 | -31.54 Million USD | -59.91% |
| 2013 Q2 | -12.63 Million USD | -26.38% |
| 2013 Q1 | -9.99 Million USD | -24.41% |
| 2013 FY | -51.98 Million USD | -82.35% |
| 2013 Q4 | -14.05 Million USD | 8.14% |
| 2013 Q3 | -15.3 Million USD | -21.11% |
| 2012 FY | -28.5 Million USD | -47.22% |
| 2012 Q2 | -5.92 Million USD | 19.3% |
| 2012 Q3 | -7.21 Million USD | -21.91% |
| 2012 Q4 | -8.03 Million USD | -11.33% |
| 2012 Q1 | -7.33 Million USD | -98.0% |
| 2011 Q4 | -3.7 Million USD | -15.35% |
| 2011 FY | -19.36 Million USD | 45.77% |
| 2011 Q1 | -7.45 Million USD | -65.11% |
| 2011 Q2 | -4.99 Million USD | 33.01% |
| 2011 Q3 | -3.21 Million USD | 35.67% |
| 2010 FY | -35.7 Million USD | 6.95% |
| 2010 Q2 | -9.42 Million USD | 17.4% |
| 2010 Q1 | -11.41 Million USD | 18.22% |
| 2010 Q4 | -4.51 Million USD | 56.41% |
| 2010 Q3 | -10.35 Million USD | -9.86% |
| 2009 Q3 | -7.53 Million USD | 11.83% |
| 2009 FY | -38.37 Million USD | -6.45% |
| 2009 Q2 | -8.54 Million USD | -2.29% |
| 2009 Q4 | -13.95 Million USD | -85.33% |
| 2009 Q1 | -8.34 Million USD | 24.65% |
| 2008 Q1 | -7.75 Million USD | 15.86% |
| 2008 FY | -36.04 Million USD | -3.69% |
| 2008 Q4 | -11.08 Million USD | -41.29% |
| 2008 Q3 | -7.84 Million USD | 16.33% |
| 2008 Q2 | -9.37 Million USD | -20.85% |
| 2007 Q1 | -8.38 Million USD | -36.43% |
| 2007 Q4 | -9.21 Million USD | -2.8% |
| 2007 FY | -34.76 Million USD | -50.71% |
| 2007 Q3 | -8.96 Million USD | -9.42% |
| 2007 Q2 | -8.19 Million USD | 2.31% |
| 2006 Q1 | -5.49 Million USD | -189.28% |
| 2006 Q3 | -5.01 Million USD | 21.79% |
| 2006 Q2 | -6.41 Million USD | -16.67% |
| 2006 FY | -23.06 Million USD | -106.44% |
| 2006 Q4 | -6.14 Million USD | -22.62% |
| 2005 Q4 | 6.15 Million USD | 325.71% |
| 2005 Q1 | -8.88 Million USD | 13.64% |
| 2005 Q2 | -5.71 Million USD | 35.67% |
| 2005 Q3 | -2.72 Million USD | 52.29% |
| 2005 FY | -11.17 Million USD | 56.89% |
| 2004 FY | -25.92 Million USD | -50.06% |
| 2004 Q1 | -5.25 Million USD | -70.55% |
| 2004 Q2 | -7.71 Million USD | -46.77% |
| 2004 Q3 | -2.65 Million USD | 65.57% |
| 2004 Q4 | -10.28 Million USD | -287.24% |
| 2003 Q4 | -3.08 Million USD | 8.27% |
| 2003 Q3 | -3.36 Million USD | 33.15% |
| 2003 Q1 | -5.8 Million USD | -12.77% |
| 2003 Q2 | -5.02 Million USD | 13.34% |
| 2003 FY | -17.27 Million USD | 23.9% |
| 2002 FY | -22.69 Million USD | -132.91% |
| 2002 Q4 | -5.14 Million USD | 23.37% |
| 2002 Q3 | -6.71 Million USD | -22.14% |
| 2002 Q2 | -5.49 Million USD | -2.9% |
| 2002 Q1 | -5.34 Million USD | -67.36% |
| 2001 Q2 | -1.8 Million USD | 19.0% |
| 2001 Q3 | -2.51 Million USD | -38.99% |
| 2001 Q4 | -3.19 Million USD | -27.02% |
| 2001 FY | -9.74 Million USD | 20.06% |
| 2001 Q1 | -2.23 Million USD | 55.24% |
| 2000 Q3 | -3.21 Million USD | -21.66% |
| 2000 Q2 | -2.64 Million USD | -95.63% |
| 2000 Q1 | -1.35 Million USD | -35.0% |
| 2000 FY | -12.19 Million USD | -170.91% |
| 2000 Q4 | -4.98 Million USD | -55.21% |
| 1999 Q3 | -1.8 Million USD | -100.0% |
| 1999 Q2 | -900 Thousand USD | 0.0% |
| 1999 FY | -4.5 Million USD | 6.25% |
| 1999 Q1 | -900 Thousand USD | 43.75% |
| 1999 Q4 | -1 Million USD | 44.44% |
| 1998 Q2 | -1.2 Million USD | -50.0% |
| 1998 Q1 | -800 Thousand USD | 20.0% |
| 1998 FY | -4.8 Million USD | -6.67% |
| 1998 Q3 | -1.2 Million USD | 0.0% |
| 1998 Q4 | -1.6 Million USD | -33.33% |
| 1997 Q4 | -1 Million USD | 9.09% |
| 1997 Q3 | -1.1 Million USD | 0.0% |
| 1997 Q1 | -1.2 Million USD | 36.84% |
| 1997 Q2 | -1.1 Million USD | 8.33% |
| 1997 FY | -4.5 Million USD | 18.18% |
| 1996 Q2 | -1.4 Million USD | -16.67% |
| 1996 FY | -5.5 Million USD | 0.0% |
| 1996 Q3 | -1 Million USD | 28.57% |
| 1996 Q1 | -1.2 Million USD | 0.0% |
| 1996 Q4 | -1.9 Million USD | -90.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| AbCellera Biologics Inc. | -146.39 Million USD | -272.315% |
| Alkermes plc | 355.75 Million USD | 253.212% |
| Agenus Inc. | -245.76 Million USD | -121.785% |
| Aptorum Group Limited | -2.82 Million USD | -19196.641% |
| Ardelyx, Inc. | -66.06 Million USD | -725.014% |
| Dyadic International, Inc. | -6.79 Million USD | -7920.972% |
| Eton Pharmaceuticals, Inc. | -936 Thousand USD | -58133.12% |
| Lantern Pharma Inc. | -15.96 Million USD | -3314.847% |
| Inhibikase Therapeutics, Inc. | -19.02 Million USD | -2764.393% |
| Janux Therapeutics, Inc. | -58.29 Million USD | -835.039% |
| Pyxis Oncology, Inc. | -73.79 Million USD | -638.666% |
| TransCode Therapeutics, Inc. | -18.54 Million USD | -2838.958% |
| Ocuphire Pharma, Inc. | -9.98 Million USD | -5358.262% |
| Outlook Therapeutics, Inc. | -58.98 Million USD | -824.105% |
| Madrigal Pharmaceuticals, Inc. | -373.63 Million USD | -45.883% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.33 Million USD | -2139.432% |
| SELLAS Life Sciences Group, Inc. | -37.34 Million USD | -1359.727% |
| Syros Pharmaceuticals, Inc. | -164.57 Million USD | -231.196% |
| Barinthus Biotherapeutics plc | -73.34 Million USD | -643.128% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | -2586.225% |
| Xeris Biopharma Holdings, Inc. | -62.25 Million USD | -775.531% |
| Clearside Biomedical, Inc. | -32.48 Million USD | -1577.888% |
| C4 Therapeutics, Inc. | -132.49 Million USD | -311.389% |
| Alnylam Pharmaceuticals, Inc. | -440.24 Million USD | -23.81% |
| AlloVir, Inc. | -190.41 Million USD | -186.245% |
| Arrowhead Pharmaceuticals, Inc. | -205.27 Million USD | -165.528% |
| VYNE Therapeutics Inc. | -28.45 Million USD | -1815.725% |
| Bicycle Therapeutics plc | -180.66 Million USD | -201.699% |
| BioXcel Therapeutics, Inc. | -179.05 Million USD | -204.414% |
| ChromaDex Corporation | -4.93 Million USD | -10938.113% |
| Chimerix, Inc. | -82.09 Million USD | -563.941% |
| Corbus Pharmaceuticals Holdings, Inc. | -44.6 Million USD | -1122.021% |
| Caribou Biosciences, Inc. | -102.07 Million USD | -434.008% |
| CRISPR Therapeutics AG | -153.61 Million USD | -254.835% |
| Precision BioSciences, Inc. | -61.31 Million USD | -788.896% |
| Fate Therapeutics, Inc. | -160.92 Million USD | -238.699% |
| Fortress Biotech, Inc. | -60.63 Million USD | -798.893% |
| Fortress Biotech, Inc. | -60.63 Million USD | -798.893% |
| HOOKIPA Pharma Inc. | -81.58 Million USD | -568.132% |
| ImmuCell Corporation | -5.77 Million USD | -9338.96% |
| IDEAYA Biosciences, Inc. | -112.96 Million USD | -382.522% |
| Immix Biopharma, Inc. | -15.42 Million USD | -3433.387% |
| Incyte Corporation | 597.59 Million USD | 191.209% |
| Innoviva, Inc. | 179.72 Million USD | 403.281% |
| IO Biotech, Inc. | -86.08 Million USD | -533.182% |
| Jaguar Health, Inc. | -41.3 Million USD | -1219.763% |
| Keros Therapeutics, Inc. | -152.99 Million USD | -256.268% |
| Ligand Pharmaceuticals Incorporated | 52.15 Million USD | 1145.101% |
| ContextLogic Inc. | -317 Million USD | -71.944% |
| MiMedx Group, Inc. | 67.43 Million USD | 908.23% |
| MEI Pharma, Inc. | 17.77 Million USD | 3165.935% |
| NextCure, Inc. | -62.72 Million USD | -768.999% |
| Onconetix, Inc. | -37.4 Million USD | -1357.007% |
| Oncternal Therapeutics, Inc. | -39.47 Million USD | -1280.638% |
| Opthea Limited | -220.24 Million USD | -147.483% |
| Psyence Biomedical Ltd. | -51.15 Million USD | -965.426% |
| Vaxcyte, Inc. | -402.26 Million USD | -35.498% |
| PDS Biotechnology Corporation | -42.94 Million USD | -1169.292% |
| Precigen, Inc. | -95.9 Million USD | -468.341% |
| Pharming Group N.V. | -10.54 Million USD | -5067.444% |
| Phathom Pharmaceuticals, Inc. | -201.59 Million USD | -170.379% |
| Pieris Pharmaceuticals, Inc. | -24.54 Million USD | -2120.845% |
| PureTech Health plc | -65.69 Million USD | -729.66% |
| Rigel Pharmaceuticals, Inc. | -25.09 Million USD | -2072.341% |
| Avidity Biosciences, Inc. | -212.22 Million USD | -156.838% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.33 Million USD | -2139.432% |
| Sangamo Therapeutics, Inc. | -257.83 Million USD | -111.403% |
| Sol-Gel Technologies Ltd. | -27.23 Million USD | -1901.109% |
| Acelyrin, Inc. | -381.64 Million USD | -42.821% |
| Salarius Pharmaceuticals, Inc. | -12.54 Thousand USD | -4345554.72% |
| Summit Therapeutics Inc. | -614.92 Million USD | 11.362% |
| Sensei Biotherapeutics, Inc. | -34.1 Million USD | -1498.375% |
| Senti Biosciences, Inc. | -92.91 Million USD | -486.599% |
| Stoke Therapeutics, Inc. | -104.69 Million USD | -420.599% |
| Elevation Oncology, Inc. | -45.7 Million USD | -1092.591% |
| Alaunos Therapeutics, Inc. | -35.14 Million USD | -1451.116% |
| Telomir Pharmaceuticals, Inc. Common Stock | -13.07 Million USD | -4069.734% |
| Entrada Therapeutics, Inc. | -6.68 Million USD | -8053.508% |
| VistaGen Therapeutics, Inc. | -29.36 Million USD | -1756.352% |
| Kintara Therapeutics, Inc. | -8.5 Million USD | -6311.74% |
| Wave Life Sciences Ltd. | -57.51 Million USD | -847.72% |
| Seer, Inc. | -86.27 Million USD | -531.758% |
| Verrica Pharmaceuticals Inc. | -66.99 Million USD | -713.586% |
| Aadi Bioscience, Inc. | -65.76 Million USD | -728.803% |
| ESSA Pharma Inc. | -26.58 Million USD | -1950.466% |
| GlycoMimetics, Inc. | -36.89 Million USD | -1377.156% |
| GT Biopharma, Inc. | -7.59 Million USD | -7074.701% |
| Inhibrx Biosciences, Inc. | -241.36 Million USD | -125.829% |
| Akebia Therapeutics, Inc. | -51.92 Million USD | -949.71% |
| Catalyst Pharmaceuticals, Inc. | 71.41 Million USD | 863.285% |
| Longboard Pharmaceuticals, Inc. | -54.42 Million USD | -901.547% |
| Orchestra BioMed Holdings, Inc. | -49.12 Million USD | -1009.654% |
| Alzamend Neuro, Inc. | -9.94 Million USD | -5379.251% |
| Sorrento Therapeutics, Inc. | -572.84 Million USD | 4.85% |
| TRACON Pharmaceuticals, Inc. | -3.58 Million USD | -15091.249% |
| Viracta Therapeutics, Inc. | -51.05 Million USD | -967.535% |
| Rocket Pharmaceuticals, Inc. | -245.59 Million USD | -121.935% |
| Aptose Biosciences Inc. | -51.2 Million USD | -964.429% |
| ZyVersa Therapeutics, Inc. | -98.29 Million USD | -454.5% |
| Soligenix, Inc. | -6.14 Million USD | -8776.176% |
| Century Therapeutics, Inc. | -136.67 Million USD | -298.807% |
| Kura Oncology, Inc. | -152.63 Million USD | -257.111% |
| TScan Therapeutics, Inc. | -89.21 Million USD | -510.933% |
| Intensity Therapeutics, Inc. | -10.53 Million USD | -5072.348% |
| Ocean Biomedical, Inc. | 565.47 Thousand USD | 96490.967% |
| CytomX Therapeutics, Inc. | -569 Thousand USD | -95692.97% |
| Autolus Therapeutics plc | -208.38 Million USD | -161.567% |
| Mineralys Therapeutics, Inc. | -71.89 Million USD | -658.105% |
| EyePoint Pharmaceuticals, Inc. | -70.79 Million USD | -669.916% |
| Eterna Therapeutics Inc. | -21.66 Million USD | -2415.516% |
| Adaptive Biotechnologies Corporation | -225.25 Million USD | -141.981% |
| GRI Bio, Inc. | -13.03 Million USD | -4080.885% |
| Xenetic Biosciences, Inc. | -4.13 Million USD | -13083.014% |
| Tenaya Therapeutics, Inc. | -124.08 Million USD | -339.269% |
| IGM Biosciences, Inc. | -246.41 Million USD | -121.196% |
| INmune Bio, Inc. | -30 Million USD | -1716.389% |
| Heron Therapeutics, Inc. | -110.55 Million USD | -393.006% |
| SAB Biotherapeutics, Inc. | -42.19 Million USD | -1191.806% |
| Pasithea Therapeutics Corp. | -15.96 Million USD | -3314.821% |
| Entero Therapeutics, Inc. | -15.79 Million USD | -3350.855% |
| Milestone Pharmaceuticals Inc. | -59.68 Million USD | -813.231% |
| X4 Pharmaceuticals, Inc. | -101.16 Million USD | -438.775% |
| Atara Biotherapeutics, Inc. | -276.12 Million USD | -97.396% |
| Coherus BioSciences, Inc. | -237.89 Million USD | -129.122% |
| Verastem, Inc. | -87.36 Million USD | -523.876% |
| Abeona Therapeutics Inc. | -54.18 Million USD | -905.872% |
| Pliant Therapeutics, Inc. | -161.33 Million USD | -237.843% |
| Tonix Pharmaceuticals Holding Corp. | -116.65 Million USD | -367.231% |
| Histogen Inc. | -10.62 Million USD | -5031.927% |
| Aprea Therapeutics, Inc. | -14.28 Million USD | -3715.156% |
| Surrozen, Inc. | -43.04 Million USD | -1166.349% |
| Organovo Holdings, Inc. | -14.67 Million USD | -3615.234% |
| Lixte Biotechnology Holdings, Inc. | -5.08 Million USD | -10614.741% |
| Ovid Therapeutics Inc. | -52.33 Million USD | -941.408% |
| Panbela Therapeutics, Inc. | -25.26 Million USD | -2057.551% |
| CASI Pharmaceuticals, Inc. | -26.93 Million USD | -1923.394% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.35 Million USD | -6422.154% |
| Centessa Pharmaceuticals plc | -151.08 Million USD | -260.765% |
| Hepion Pharmaceuticals, Inc. | -48.92 Million USD | -1014.053% |
| Arcturus Therapeutics Holdings Inc. | -29.72 Million USD | -1733.682% |
| BioRestorative Therapies, Inc. | -10.41 Million USD | -5132.074% |
| Apollomics, Inc. | -172.6 Million USD | -215.793% |
| Amarin Corporation plc | -59.11 Million USD | -822.084% |
| Mesoblast Limited | -87.95 Million USD | -519.698% |
| Turnstone Biologics Corp. | -55.2 Million USD | -887.431% |
| Kymera Therapeutics, Inc. | -146.96 Million USD | -270.886% |
| Synaptogenix, Inc. | -6.03 Million USD | -8926.441% |
| Tiziana Life Sciences Ltd | -16.2 Million USD | -3262.92% |
| Aurinia Pharmaceuticals Inc. | -78.02 Million USD | -598.618% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -11275.683% |
| Monopar Therapeutics Inc. | -8.4 Million USD | -6387.137% |
| Exelixis, Inc. | 207.76 Million USD | 362.345% |
| Better Therapeutics, Inc. | -39.76 Million USD | -1270.88% |
| Nurix Therapeutics, Inc. | -143.94 Million USD | -278.652% |
| Apellis Pharmaceuticals, Inc. | -528.62 Million USD | -3.109% |
| NLS Pharmaceutics AG | -12.17 Million USD | -4377.988% |
| Dermata Therapeutics, Inc. | -7.79 Million USD | -6892.735% |
| Aridis Pharmaceuticals, Inc. | -30.74 Million USD | -1672.617% |
| Gritstone bio, Inc. | -138.49 Million USD | -293.575% |
| Jasper Therapeutics, Inc. | -64.46 Million USD | -745.516% |
| TNF Pharmaceuticals, Inc. | -3.99 Million USD | -13526.72% |
| Avid Bioservices, Inc. | -140.75 Million USD | -287.247% |
| Insmed Incorporated | -749.56 Million USD | 27.283% |
| Virpax Pharmaceuticals, Inc. | -15.18 Million USD | -3488.411% |
| MediWound Ltd. | -6.71 Million USD | -8015.873% |
| OmniAb, Inc. | -50.61 Million USD | -976.793% |
| Alector, Inc. | -130.39 Million USD | -318.021% |
| Seres Therapeutics, Inc. | -113.72 Million USD | -379.285% |
| Checkpoint Therapeutics, Inc. | -51.84 Million USD | -951.289% |
| Zai Lab Limited | -334.62 Million USD | -62.89% |
| Revance Therapeutics, Inc. | -323.98 Million USD | -68.236% |
| Aura Biosciences, Inc. | -76.4 Million USD | -613.357% |
| Lyell Immunopharma, Inc. | -234.63 Million USD | -132.305% |
| Immunic, Inc. | -93.61 Million USD | -482.257% |
| Tarsus Pharmaceuticals, Inc. | -135.89 Million USD | -301.096% |
| Veracyte, Inc. | -74.4 Million USD | -632.571% |
| InMed Pharmaceuticals Inc. | -7.67 Million USD | -7001.276% |
| FibroGen, Inc. | -284.23 Million USD | -91.767% |
| SeaStar Medical Holding Corporation | -26.23 Million USD | -1977.851% |
| Adial Pharmaceuticals, Inc. | -7 Million USD | -7684.498% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.83 Million USD | -2794.233% |
| Jazz Pharmaceuticals plc | 414.83 Million USD | 231.393% |
| Cyclacel Pharmaceuticals, Inc. | -22.55 Million USD | -2316.591% |
| Amylyx Pharmaceuticals, Inc. | 49.27 Million USD | 1206.253% |
| TG Therapeutics, Inc. | 12.67 Million USD | 4401.31% |
| Galecto, Inc. | -38.34 Million USD | -1321.32% |
| Calithera Biosciences, Inc. | -18.86 Million USD | -2789.123% |
| Fortrea Holdings Inc. | -3.4 Million USD | -15931.235% |
| KalVista Pharmaceuticals, Inc. | -126.64 Million USD | -330.389% |
| Aptevo Therapeutics Inc. | -17.41 Million USD | -3030.561% |
| XBiotech Inc. | -24.55 Million USD | -2119.579% |
| Jasper Therapeutics, Inc. | -64.46 Million USD | -745.516% |
| Lyra Therapeutics, Inc. | -62.68 Million USD | -769.595% |
| Foghorn Therapeutics Inc. | -98.42 Million USD | -453.778% |
| Y-mAbs Therapeutics, Inc. | -21.42 Million USD | -2443.809% |
| Theravance Biopharma, Inc. | -55.19 Million USD | -887.556% |
| Ultragenyx Pharmaceutical Inc. | -606.63 Million USD | 10.151% |
| Metagenomi, Inc. Common Stock | -68.25 Million USD | -698.567% |
| Vaxxinity, Inc. | -56.93 Thousand USD | -957257.642% |
| BioCryst Pharmaceuticals, Inc. | -226.53 Million USD | -140.604% |
| Gain Therapeutics, Inc. | -22.26 Million USD | -2347.789% |
| Cartesian Therapeutics, Inc. | -219.71 Million USD | -148.082% |
| NexImmune, Inc. | -32.34 Million USD | -1585.182% |
| Creative Medical Technology Holdings, Inc. | -5.28 Million USD | -10210.307% |
| Marker Therapeutics, Inc. | -14.04 Million USD | -3780.579% |
| Regeneron Pharmaceuticals, Inc. | 3.95 Billion USD | 113.786% |
| Chemomab Therapeutics Ltd. | -24.22 Million USD | -2150.37% |
| Scopus BioPharma Inc. | -11.6 Million USD | -4594.833% |
| RAPT Therapeutics, Inc. | -116.79 Million USD | -366.671% |
| Ainos, Inc. | -13.77 Million USD | -3858.172% |
| Pluri Inc. | -20.88 Million USD | -2509.45% |
| Prothena Corporation plc | -147.02 Million USD | -270.72% |
| Adaptimmune Therapeutics plc | -113.87 Million USD | -378.666% |
| Celularity Inc. | -196.29 Million USD | -177.675% |
| Rallybio Corporation | -74.56 Million USD | -630.999% |
| Cue Biopharma, Inc. | -50.73 Million USD | -974.374% |
| MeiraGTx Holdings plc | -84.02 Million USD | -548.675% |
| Omeros Corporation | -117.81 Million USD | -362.65% |
| Humacyte, Inc. | -110.77 Million USD | -392.04% |
| Immunocore Holdings plc | -55.28 Million USD | -885.877% |
| Cocrystal Pharma, Inc. | -17.98 Million USD | -2930.816% |
| Cidara Therapeutics, Inc. | -22.93 Million USD | -2276.966% |
| Blueprint Medicines Corporation | -506.98 Million USD | -7.511% |
| CalciMedica, Inc. | -34.35 Million USD | -1486.466% |
| Cabaletta Bio, Inc. | -67.67 Million USD | -705.411% |
| Marinus Pharmaceuticals, Inc. | -141.4 Million USD | -285.462% |
| Scholar Rock Holding Corporation | -165.78 Million USD | -228.768% |
| Sana Biotechnology, Inc. | -283.25 Million USD | -92.428% |
| Pulmatrix, Inc. | -14.12 Million USD | -3759.939% |
| Elicio Therapeutics, Inc. | -35.19 Million USD | -1448.692% |
| Vigil Neuroscience, Inc. | -82.63 Million USD | -559.578% |
| Intellia Therapeutics, Inc. | -481.19 Million USD | -13.273% |
| Adlai Nortye Ltd. American Depositary Shares | -104.87 Million USD | -419.745% |
| Cytokinetics, Incorporated | -526.24 Million USD | -3.576% |
| Eloxx Pharmaceuticals, Inc. | -36.06 Million USD | -1411.332% |
| Nutriband Inc. | -5.48 Million USD | -9836.751% |
| Protara Therapeutics, Inc. | -40.42 Million USD | -1248.496% |
| Vor Biopharma Inc. | -117.86 Million USD | -362.454% |
| Roivant Sciences Ltd. | 4.34 Billion USD | 112.533% |
| Evogene Ltd. | -23.87 Million USD | -2182.6% |
| ProKidney Corp. | -35.46 Million USD | -1436.771% |
| Applied Therapeutics, Inc. | -119.76 Million USD | -355.117% |
| Hoth Therapeutics, Inc. | -7.84 Million USD | -6847.545% |
| BridgeBio Pharma, Inc. | -643.2 Million USD | 15.258% |
| CorMedix Inc. | -46.33 Million USD | -1076.243% |
| BioLineRx Ltd. | -60.61 Million USD | -799.235% |
| Tango Therapeutics, Inc. | -101.74 Million USD | -435.719% |
| Galectin Therapeutics Inc. | -41.06 Million USD | -1227.283% |
| Atai Life Sciences N.V. | -40.22 Million USD | -1255.067% |
| Renovaro Biosciences Inc. | -80.65 Million USD | -575.835% |
| Aerovate Therapeutics, Inc. | -75.52 Million USD | -621.736% |
| Zentalis Pharmaceuticals, Inc. | -292.19 Million USD | -86.543% |
| Sagimet Biosciences Inc. | -27.87 Million USD | -1855.309% |
| MediciNova, Inc. | -8.57 Million USD | -6258.992% |
| Praxis Precision Medicines, Inc. | -123.27 Million USD | -342.144% |
| Cardio Diagnostics Holdings, Inc. | -8.37 Million USD | -6406.778% |
| GeoVax Labs, Inc. | -25.96 Million USD | -1999.076% |
| Axsome Therapeutics, Inc. | -239.23 Million USD | -127.833% |
| Biomea Fusion, Inc. | -117.25 Million USD | -364.852% |
| PTC Therapeutics, Inc. | -626.6 Million USD | 13.013% |
| Mereo BioPharma Group plc | -29.46 Million USD | -1749.8% |
| Cullinan Oncology, Inc. | -153.16 Million USD | -255.873% |
| Syndax Pharmaceuticals, Inc. | -209.36 Million USD | -160.347% |
| Absci Corporation | -110.56 Million USD | -392.974% |
| NRx Pharmaceuticals, Inc. | -30.15 Million USD | -1707.834% |
| 4D Molecular Therapeutics, Inc. | -100.83 Million USD | -440.538% |
| Dyne Therapeutics, Inc. | -235.93 Million USD | -131.02% |
| Kiniksa Pharmaceuticals, Ltd. | 14.08 Million USD | 3970.08% |
| Ventyx Biosciences, Inc. | -192.96 Million USD | -182.471% |
| Allakos Inc. | -185.7 Million USD | -193.516% |
| Imunon, Inc. | -19.51 Million USD | -2693.045% |
| Fulcrum Therapeutics, Inc. | -97.33 Million USD | -459.986% |
| Corcept Therapeutics Incorporated | 106.14 Million USD | 613.531% |
| BioAtla, Inc. | -123.46 Million USD | -341.482% |
| NLS Pharmaceutics AG | -12.17 Million USD | -4377.988% |
| Bio-Path Holdings, Inc. | -16.07 Million USD | -3290.111% |
| Allogene Therapeutics, Inc. | -327.26 Million USD | -66.551% |
| Larimar Therapeutics, Inc. | -36.94 Million USD | -1375.174% |
| XOMA Corporation | -40.83 Million USD | -1234.922% |
| Kezar Life Sciences, Inc. | -101.87 Million USD | -435.056% |
| Cara Therapeutics, Inc. | -118.51 Million USD | -359.917% |
| aTyr Pharma, Inc. | -50.38 Million USD | -981.708% |
| Aligos Therapeutics, Inc. | -87.67 Million USD | -521.656% |
| Akero Therapeutics, Inc. | -151.75 Million USD | -259.163% |
| Viridian Therapeutics, Inc. | -237.73 Million USD | -129.274% |
| Eliem Therapeutics, Inc. | -35.11 Million USD | -1452.043% |
| EyeGate Pharmaceuticals, Inc. | -8.09 Million USD | -6635.863% |
| Akari Therapeutics, Plc | -10 Million USD | -5346.263% |
| Tevogen Bio Holdings Inc. | -67.32 Thousand USD | -809498.218% |
| Halozyme Therapeutics, Inc. | 281.59 Million USD | 293.563% |
| Lexaria Bioscience Corp. | -6.66 Million USD | -8078.098% |
| UroGen Pharma Ltd. | -102.24 Million USD | -433.099% |
| Sutro Biopharma, Inc. | -106.79 Million USD | -410.391% |
| ZIVO Bioscience, Inc. | -7.77 Million USD | -6908.475% |
| Orgenesis Inc. | -55.36 Million USD | -884.56% |
| Entera Bio Ltd. | -8.88 Million USD | -6031.871% |
| GH Research PLC | -35.58 Million USD | -1431.632% |
| Lisata Therapeutics, Inc. | -20.84 Million USD | -2515.461% |
| Reneo Pharmaceuticals, Inc. | -77.38 Million USD | -604.324% |
| Xencor, Inc. | -126.08 Million USD | -332.29% |
| 60 Degrees Pharmaceuticals, Inc. | -3.76 Million USD | -14374.38% |
| Replimune Group, Inc. | -215.79 Million USD | -152.584% |
| Coeptis Therapeutics Holdings, Inc. | -21.26 Million USD | -2463.003% |
| Vanda Pharmaceuticals Inc. | 2.5 Million USD | 21824.273% |
| Lexaria Bioscience Corp. | -6.66 Million USD | -8078.098% |
| Portage Biotech Inc. | -75.33 Million USD | -623.479% |
| Cardio Diagnostics Holdings, Inc. | -8.37 Million USD | -6406.778% |
| Olema Pharmaceuticals, Inc. | -96.65 Million USD | -463.925% |
| OncoCyte Corporation | -27.78 Million USD | -1861.996% |
| Qualigen Therapeutics, Inc. | -13.41 Million USD | -3962.409% |
| Processa Pharmaceuticals, Inc. | -11.12 Million USD | -4800.967% |
| Purple Biotech Ltd. | -19.88 Million USD | -2641.761% |
| CollPlant Biotechnologies Ltd. | -7.01 Million USD | -7665.522% |
| scPharmaceuticals Inc. | -54.81 Million USD | -894.457% |
| ProMIS Neurosciences, Inc. | -17.5 Million USD | -3013.547% |
| HilleVax, Inc. | -123.56 Million USD | -341.11% |
| NeuroSense Therapeutics Ltd. | -10.1 Million USD | -5292.916% |
| Tharimmune, Inc. | -9.31 Million USD | -5748.873% |
| Genprex, Inc. | -30.86 Million USD | -1666.215% |
| Neumora Therapeutics, Inc. Common Stock | -235.92 Million USD | -131.032% |
| Atossa Therapeutics, Inc. | -30.09 Million USD | -1711.198% |
| XTL Biopharmaceuticals Ltd. | -1.78 Million USD | -30487.093% |
| Virios Therapeutics, Inc. | -5.29 Million USD | -10191.927% |
| OKYO Pharma Limited | -16.82 Thousand USD | -3239407.271% |
| Savara Inc. | -54.69 Million USD | -896.493% |
| Curis, Inc. | -47.41 Million USD | -1049.605% |
| Daré Bioscience, Inc. | -30.16 Million USD | -1707.151% |
| Carmell Therapeutics Corporation | -15.44 Million USD | -3429.032% |
| Titan Pharmaceuticals, Inc. | -5.56 Million USD | -9687.43% |
| Achieve Life Sciences, Inc. | -29.81 Million USD | -1728.147% |
| BeiGene, Ltd. | -881.7 Million USD | 38.181% |
| Kiromic BioPharma, Inc. | -21.29 Million USD | -2459.698% |
| Revolution Medicines, Inc. Warrant | -436.36 Million USD | -24.909% |
| Protagonist Therapeutics, Inc. | -78.95 Million USD | -590.345% |
| Erasca, Inc. | -125.04 Million USD | -335.903% |
| bluebird bio, Inc. | -211.91 Million USD | -157.21% |
| Protagenic Therapeutics, Inc. | -5 Million USD | -10800.157% |
| BioMarin Pharmaceutical Inc. | 167.64 Million USD | 425.129% |
| DBV Technologies S.A. | -72.72 Million USD | -649.473% |
| Protagenic Therapeutics, Inc. | -5 Million USD | -10800.157% |
| Moderna, Inc. | -4.71 Billion USD | 88.437% |
| Vincerx Pharma, Inc. | -40.15 Million USD | -1257.327% |
| Fresh Tracks Therapeutics, Inc. | -5.69 Million USD | -9472.568% |
| Molecular Templates, Inc. | -8.12 Million USD | -6609.281% |
| Acrivon Therapeutics, Inc. Common Stock | -60.38 Million USD | -802.6% |
| Travere Therapeutics, Inc. | -111.39 Million USD | -389.288% |
| Monte Rosa Therapeutics, Inc. | -135.35 Million USD | -302.7% |
| Spruce Biosciences, Inc. | -47.91 Million USD | -1037.465% |
| Celldex Therapeutics, Inc. | -141.42 Million USD | -285.396% |
| Cogent Biosciences, Inc. | -192.41 Million USD | -183.282% |
| MacroGenics, Inc. | -9.05 Million USD | -5917.465% |
| RenovoRx, Inc. | -10.23 Million USD | -5227.033% |
| Adicet Bio, Inc. | -142.65 Million USD | -282.076% |
| Prime Medicine, Inc. | -198.13 Million USD | -175.099% |
| Aditxt, Inc. | -32.38 Million USD | -1583.286% |
| Adagene Inc. | -18.94 Million USD | -2776.868% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -7354.631% |
| Quantum-Si incorporated | -95.96 Million USD | -468.01% |
| Maravai LifeSciences Holdings, Inc. | -119.02 Million USD | -357.924% |
| Acurx Pharmaceuticals, Inc. | -14.57 Million USD | -3638.995% |
| Voyager Therapeutics, Inc. | 132.33 Million USD | 511.896% |
| SciSparc Ltd. | -5.12 Million USD | -10541.585% |
| Vericel Corporation | -3.18 Million USD | -17029.541% |
| Revelation Biosciences, Inc. | -120.25 Thousand USD | -453158.935% |
| Minerva Neurosciences, Inc. | -30 Million USD | -1716.549% |
| Generation Bio Co. | -126.61 Million USD | -330.498% |
| Astria Therapeutics, Inc. | -72.89 Million USD | -647.777% |
| Black Diamond Therapeutics, Inc. | -82.44 Million USD | -561.146% |
| Arcutis Biotherapeutics, Inc. | -262.14 Million USD | -107.928% |
| Invivyd, Inc. | -198.64 Million USD | -174.393% |
| Relay Therapeutics, Inc. | -341.97 Million USD | -59.387% |
| Quoin Pharmaceuticals, Ltd. | -8.68 Million USD | -6174.765% |
| Spero Therapeutics, Inc. | 22.8 Million USD | 2489.994% |
| Artelo Biosciences, Inc. | -9.87 Million USD | -5420.174% |
| 2seventy bio, Inc. | -217.57 Million USD | -150.523% |
| ADMA Biologics, Inc. | -28.23 Million USD | -1830.175% |
| Clene Inc. | -49.5 Million USD | -1001.046% |
| Capricor Therapeutics, Inc. | -22.28 Million USD | -2345.59% |
| Boundless Bio, Inc. Common Stock | -49.43 Million USD | -1002.605% |
| GeoVax Labs, Inc. | -25.96 Million USD | -1999.076% |
| Recursion Pharmaceuticals, Inc. | -328.06 Million USD | -66.144% |
| Citius Pharmaceuticals, Inc. | -32.54 Million USD | -1574.902% |
| Contineum Therapeutics, Inc. Class A Common Stock | 22.72 Million USD | 2499.04% |
| Relmada Therapeutics, Inc. | -98.79 Million USD | -451.728% |
| Finch Therapeutics Group, Inc. | -74.75 Million USD | -629.141% |
| ALX Oncology Holdings Inc. | -160.8 Million USD | -238.958% |
| Vir Biotechnology, Inc. | -615.06 Million USD | 11.381% |
| Evaxion Biotech A/S | -22.12 Million USD | -2363.557% |
| Ocular Therapeutix, Inc. | -80.73 Million USD | -575.116% |
| Verve Therapeutics, Inc. | -200.06 Million USD | -172.438% |
| Trevena, Inc. | -40.28 Million USD | -1252.88% |
| Surrozen, Inc. | -43.04 Million USD | -1166.349% |
| Tyra Biosciences, Inc. | -69.13 Million USD | -688.414% |
| Cingulate Inc. | -23.53 Million USD | -2215.969% |
| Galmed Pharmaceuticals Ltd. | -6.91 Million USD | -7785.735% |
| Unity Biotechnology, Inc. | -39.86 Million USD | -1267.441% |
| Tenax Therapeutics, Inc. | -7.71 Million USD | -6968.929% |
| Terns Pharmaceuticals, Inc. | -90.21 Million USD | -504.215% |
| ACADIA Pharmaceuticals Inc. | -61.28 Million USD | -789.374% |
| Connect Biopharma Holdings Limited | -59.5 Million USD | -816.024% |
| Clearmind Medicine Inc. | -11.95 Million USD | -4459.269% |
| Kronos Bio, Inc. | -112.67 Million USD | -383.756% |
| Bolt Biotherapeutics, Inc. | -69.19 Million USD | -687.696% |
| CERo Therapeutics Holdings, Inc. | -2536.23 USD | -21490931.965% |
| Viking Therapeutics, Inc. | -85.89 Million USD | -534.568% |
| Statera Biopharma, Inc. | -174.4 Million USD | -212.521% |
| ImmunityBio, Inc. | -583.19 Million USD | 6.539% |
| Korro Bio, Inc. | -81.17 Million USD | -571.49% |
| Kineta, Inc. | -14.09 Million USD | -3765.962% |
| BioVie Inc. | -32.12 Million USD | -1596.927% |
| Codexis, Inc. | -76.24 Million USD | -614.929% |
| Celularity Inc. | -196.29 Million USD | -177.675% |
| Crinetics Pharmaceuticals, Inc. | -214.52 Million USD | -154.074% |
| Celcuity Inc. | -63.77 Million USD | -754.609% |
| Virax Biolabs Group Limited | -6.73 Million USD | -7994.735% |
| Cibus, Inc. | -267.62 Million USD | -103.665% |
| Eledon Pharmaceuticals, Inc. | -40.32 Million USD | -1251.639% |
| eFFECTOR Therapeutics, Inc. | -35.81 Million USD | -1422.052% |
| IN8bio, Inc. | -30 Million USD | -1716.449% |
| Kodiak Sciences Inc. | -260.49 Million USD | -109.244% |
| Annexon, Inc. | -134.23 Million USD | -306.045% |
| Adverum Biotechnologies, Inc. | -117.16 Million USD | -365.209% |
| Assembly Biosciences, Inc. | -61.22 Million USD | -790.217% |
| Avalo Therapeutics, Inc. | -31.54 Million USD | -1627.942% |
| Ionis Pharmaceuticals, Inc. | -366.28 Million USD | -48.808% |
| Eyenovia, Inc. | -27.26 Million USD | -1899.413% |
| Puma Biotechnology, Inc. | 21.59 Million USD | 2624.487% |
| Conduit Pharmaceuticals Inc. | -535 Thousand USD | -101780.748% |
| Xilio Therapeutics, Inc. | -76.4 Million USD | -613.395% |
| Arcellx, Inc. | -70.69 Million USD | -671.06% |
| Cardiff Oncology, Inc. | -41.44 Million USD | -1215.272% |
| Enanta Pharmaceuticals, Inc. | -133.81 Million USD | -307.322% |
| Regulus Therapeutics Inc. | -30.03 Million USD | -1714.635% |
| Moolec Science SA | -51.78 Million USD | -952.469% |
| Acumen Pharmaceuticals, Inc. | -52.37 Million USD | -940.771% |
| Geron Corporation | -184.12 Million USD | -196.025% |
| LAVA Therapeutics N.V. | -41.97 Million USD | -1198.571% |
| Royalty Pharma plc | 1.13 Billion USD | 148.03% |
| Atea Pharmaceuticals, Inc. | -135.95 Million USD | -300.911% |
| Greenwich LifeSciences, Inc. | -8.89 Million USD | -6029.938% |
| TFF Pharmaceuticals, Inc. | -21.24 Million USD | -2465.815% |
| Mersana Therapeutics, Inc. | -171.67 Million USD | -217.506% |
| Humacyte, Inc. | -110.77 Million USD | -392.04% |
| Structure Therapeutics Inc. | -89.62 Million USD | -508.192% |
| 89bio, Inc. | -142.18 Million USD | -283.336% |
| PMV Pharmaceuticals, Inc. | -68.96 Million USD | -690.403% |
| Avenue Therapeutics, Inc. | -10.37 Million USD | -5152.597% |
| Genelux Corporation | -28.29 Million USD | -1826.218% |
| Trevi Therapeutics, Inc. | -29.06 Million USD | -1775.321% |
| Lexicon Pharmaceuticals, Inc. | -177.11 Million USD | -207.738% |
| Notable Labs, Ltd. | -11.26 Million USD | -4738.974% |
| Liquidia Corporation | -78.5 Million USD | -594.329% |
| Mustang Bio, Inc. | -51.6 Million USD | -956.281% |
| Immunovant, Inc. | -259.33 Million USD | -110.176% |
| Quantum-Si incorporated | -95.96 Million USD | -468.01% |
| Arbutus Biopharma Corporation | -72.84 Million USD | -648.208% |
| DiaMedica Therapeutics Inc. | -19.38 Million USD | -2712.352% |
| Vera Therapeutics, Inc. | -95.99 Million USD | -467.832% |
| Acasti Pharma Inc. | -12.85 Million USD | -4140.738% |
| MiNK Therapeutics, Inc. | -22.45 Million USD | -2327.043% |
| Pasithea Therapeutics Corp. | -15.96 Million USD | -3314.821% |
| Xenon Pharmaceuticals Inc. | -182.39 Million USD | -198.839% |
| Elevai Labs, Inc. Common Stock | -4.3 Million USD | -12571.39% |
| NeuroBo Pharmaceuticals, Inc. | -12.47 Million USD | -4270.986% |
| Tempest Therapeutics, Inc. | -29.49 Million USD | -1748.232% |
| Soleno Therapeutics, Inc. | -38.98 Million USD | -1298.025% |
| PepGen Inc. | -78.62 Million USD | -593.234% |
| Moleculin Biotech, Inc. | -29.76 Million USD | -1730.972% |
| United Therapeutics Corporation | 984.8 Million USD | 155.347% |
| Nuvectis Pharma, Inc. | -22.26 Million USD | -2348.616% |
| Solid Biosciences Inc. | -96.01 Million USD | -467.684% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -11275.683% |
| Immuneering Corporation | -53.47 Million USD | -919.348% |
| Lixte Biotechnology Holdings, Inc. | -5.08 Million USD | -10614.741% |
| Silo Pharma, Inc. | -3.7 Million USD | -14628.687% |
| Belite Bio, Inc | -31.63 Million USD | -1623.135% |
| XOMA Corporation | -40.83 Million USD | -1234.922% |
| ARS Pharmaceuticals, Inc. | -54.36 Million USD | -902.597% |
| Bionomics Limited | -15.49 Billion USD | 96.482% |
| Apogee Therapeutics, Inc. | -83.98 Million USD | -548.999% |
| Alpha Tau Medical Ltd. | -29.15 Million USD | -1769.404% |
| uniQure N.V. | -308.47 Million USD | -76.694% |
| Cassava Sciences, Inc. | -97.21 Million USD | -460.665% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -7354.631% |
| Poseida Therapeutics, Inc. | -123.43 Million USD | -341.596% |
| Forte Biosciences, Inc. | -31.47 Million USD | -1631.675% |
| Anebulo Pharmaceuticals, Inc. | -8.2 Million USD | -6545.717% |
| Enlivex Therapeutics Ltd. | -29.06 Million USD | -1775.127% |
| Conduit Pharmaceuticals Inc. | -535 Thousand USD | -101780.748% |
| SeaStar Medical Holding Corporation | -26.23 Million USD | -1977.851% |
| FibroBiologics, Inc. Common Stock | -16.48 Million USD | -3206.412% |
| Altimmune, Inc. | -88.44 Million USD | -516.258% |
| Amicus Therapeutics, Inc. | -151.58 Million USD | -259.578% |
| Alpha Tau Medical Ltd. | -29.15 Million USD | -1769.404% |
| Compugen Ltd. | -18.75 Million USD | -2806.377% |
| Peak Bio, Inc. | -1259.26 USD | -43284209.833% |
| Zevra Therapeutics, Inc. | -46.04 Million USD | -1083.657% |
| Benitec Biopharma Inc. | -21.75 Million USD | -2405.917% |
| Spyre Therapeutics, Inc. | -338.79 Million USD | -60.885% |
| NKGen Biotech, Inc. Common Stock | -82.95 Million USD | -557.065% |
| Zura Bio Limited | -60.36 Million USD | -803.019% |
| PolyPid Ltd. | -23.86 Million USD | -2183.939% |
| Aileron Therapeutics, Inc. | -15.73 Million USD | -3364.671% |
| NKGen Biotech, Inc. Warrants | -82.95 Million USD | -557.065% |
| Instil Bio, Inc. | -156.08 Million USD | -249.204% |
| argenx SE | -295.05 Million USD | -84.734% |
| Immunome, Inc. | -106.8 Million USD | -410.329% |
| Compass Therapeutics, Inc. | -42.49 Million USD | -1182.68% |
| Verona Pharma plc | -54.36 Million USD | -902.523% |
| enGene Holdings Inc. Warrants | -99.91 Million USD | -445.515% |
| Shattuck Labs, Inc. | -87.29 Million USD | -524.369% |
| CervoMed Inc. | -2.17 Million USD | -24996.403% |
| LENZ Therapeutics, Inc. | -124.65 Million USD | -337.27% |
| Plus Therapeutics, Inc. | -13.31 Million USD | -3993.286% |
| Dianthus Therapeutics, Inc. | -43.55 Million USD | -1151.434% |
| Moolec Science SA | -51.78 Million USD | -952.469% |
| Enveric Biosciences, Inc. | -17.29 Thousand USD | -3152054.238% |
| Inovio Pharmaceuticals, Inc. | -135.11 Million USD | -303.399% |
| AnaptysBio, Inc. | -163.61 Million USD | -233.129% |
| Design Therapeutics, Inc. | -66.86 Million USD | -715.204% |
| Leap Therapeutics, Inc. | -81.41 Million USD | -569.494% |
| NeurAxis, Inc. | -14.62 Million USD | -3626.491% |
| Seelos Therapeutics, Inc. | -37.88 Million USD | -1338.842% |
| Lumos Pharma, Inc. | -34.03 Million USD | -1501.522% |
| Achilles Therapeutics plc | -69.66 Million USD | -682.404% |
| enGene Holdings Inc. Common Stock | -99.91 Million USD | -445.515% |
| 180 Life Sciences Corp. | -19.93 Million USD | -2634.181% |
| Opiant Pharmaceuticals, Inc. | 3 Million USD | 18215.654% |
| CERo Therapeutics Holdings, Inc. | -2536.23 USD | -21490931.965% |
| Nutriband Inc. | -5.48 Million USD | -9836.751% |
| ORIC Pharmaceuticals, Inc. | -100.69 Million USD | -441.289% |
| CG Oncology, Inc. Common stock | -48.6 Million USD | -1021.365% |
| Fractyl Health, Inc. Common Stock | -77.09 Million USD | -607.037% |
| Rani Therapeutics Holdings, Inc. | -33.97 Million USD | -1504.539% |
| MoonLake Immunotherapeutics | -36 Million USD | -1413.756% |
| Palisade Bio, Inc. | -12.3 Million USD | -4331.398% |
| Tourmaline Bio, Inc. | -42.12 Million USD | -1193.946% |
| Beam Therapeutics Inc. | -132.52 Million USD | -311.284% |
| Neurogene Inc. | -36.31 Million USD | -1400.845% |
| Mirum Pharmaceuticals, Inc. | -163.41 Million USD | -233.545% |
| AEON Biopharma, Inc. | -52.55 Million USD | -937.107% |
| CARGO Therapeutics, Inc. Common Stock | -98.14 Million USD | -455.353% |
| Sesen Bio, Inc. | -19.88 Million USD | -2641.209% |
| Enliven Therapeutics, Inc. | -71.58 Million USD | -661.43% |
| Kiora Pharmaceuticals, Inc. | -12.51 Million USD | -4255.654% |
| Iovance Biotherapeutics, Inc. | -444.03 Million USD | -22.751% |
| Taysha Gene Therapies, Inc. | -111.56 Million USD | -388.556% |
| Athira Pharma, Inc. | -117.67 Million USD | -363.205% |
| Vaccinex, Inc. | -20.25 Million USD | -2591.531% |
| HCW Biologics Inc. | -24.99 Million USD | -2080.747% |
| XOMA Corporation | -40.83 Million USD | -1234.922% |
| Nektar Therapeutics | -276.05 Million USD | -97.446% |
| Arvinas, Inc. | -367.3 Million USD | -48.397% |
| Tevogen Bio Holdings Inc. | -67.32 Thousand USD | -809498.218% |
| Merus N.V. | -154.93 Million USD | -251.791% |
| Omega Therapeutics, Inc. | -97.42 Million USD | -459.451% |
| Quince Therapeutics, Inc. | -31.38 Million USD | -1636.696% |
| Rezolute, Inc. | -68.45 Million USD | -696.187% |
| Clene Inc. | -49.5 Million USD | -1001.046% |
| Indaptus Therapeutics, Inc. | -15.42 Million USD | -3433.978% |
| BeyondSpring Inc. | -21.02 Million USD | -2492.324% |
| Synlogic, Inc. | -57.28 Million USD | -851.541% |
| Allarity Therapeutics, Inc. | -11.9 Million USD | -4479.968% |
| Phio Pharmaceuticals Corp. | -10.82 Million USD | -4934.75% |
| Peak Bio, Inc. | -1259.26 USD | -43284209.833% |
| Werewolf Therapeutics, Inc. | -37.36 Million USD | -1358.633% |
| Krystal Biotech, Inc. | 10.93 Million USD | 5085.931% |
| Karyopharm Therapeutics Inc. | -143.09 Million USD | -280.899% |
| SpringWorks Therapeutics, Inc. | -325.1 Million USD | -67.658% |
| Lipella Pharmaceuticals Inc. | -4.61 Million USD | -11700.522% |
| MannKind Corporation | -11.93 Million USD | -4465.773% |
| Ikena Oncology, Inc. | -68.16 Million USD | -699.61% |
| Cyclerion Therapeutics, Inc. | -21.01 Million USD | -2493.681% |
| Gyre Therapeutics, Inc. | -92.93 Million USD | -486.511% |
| Gossamer Bio, Inc. | -179.81 Million USD | -203.12% |
| CohBar, Inc. | -11.96 Million USD | -4456.567% |
| Cognition Therapeutics, Inc. | -25.78 Million USD | -2013.626% |
| NRx Pharmaceuticals, Inc. | -30.15 Million USD | -1707.834% |
| Legend Biotech Corporation | -518.25 Million USD | -5.173% |
| Mural Oncology plc | -207.44 Million USD | -162.748% |
| Biora Therapeutics, Inc. | -124.11 Million USD | -339.159% |
| PaxMedica, Inc. Common Stock | -18.28 Million USD | -2880.154% |
| Disc Medicine, Inc. | -76.42 Million USD | -613.161% |
| Champions Oncology, Inc. | -7.27 Million USD | -7391.231% |
| REGENXBIO Inc. | -263.49 Million USD | -106.859% |
| Ensysce Biosciences, Inc. | -10.61 Million USD | -5035.76% |
| Anavex Life Sciences Corp. | -47.5 Million USD | -1047.378% |
| Cellectar Biosciences, Inc. | -37.98 Million USD | -1334.997% |
| Edgewise Therapeutics, Inc. | -100.16 Million USD | -444.175% |
| Vaxart, Inc. | -82.46 Million USD | -560.962% |
| PharmaCyte Biotech, Inc. | 333.76 Thousand USD | 163408.096% |
| Aldeyra Therapeutics, Inc. | -37.54 Million USD | -1351.853% |
| Cellectis S.A. | -101.05 Million USD | -439.35% |
| Longeveron Inc. | -21.41 Million USD | -2445.472% |
| Repare Therapeutics Inc. | -93.79 Million USD | -481.114% |
| Sarepta Therapeutics, Inc. | -535.97 Million USD | -1.695% |
| Inozyme Pharma, Inc. | -71.16 Million USD | -665.87% |
| Revolution Medicines, Inc. | -436.36 Million USD | -24.909% |
| Nymox Pharmaceutical Corporation | -6.57 Million USD | -8194.963% |
| Third Harmonic Bio, Inc. | -30.82 Million USD | -1668.304% |
| ArriVent BioPharma, Inc. Common Stock | -69.33 Million USD | -686.151% |
| AN2 Therapeutics, Inc. | -64.73 Million USD | -742.029% |
| Anixa Biosciences, Inc. | -9.81 Million USD | -5455.621% |
| Vertex Pharmaceuticals Incorporated | 3.61 Billion USD | 115.059% |
| Denali Therapeutics Inc. | -145.22 Million USD | -275.325% |
| Revelation Biosciences, Inc. | -120.25 Thousand USD | -453158.935% |
| Veru Inc. | -93.15 Million USD | -485.127% |
| Corvus Pharmaceuticals, Inc. | -27.02 Million USD | -1916.582% |
| Cingulate Inc. | -23.53 Million USD | -2215.969% |
| Passage Bio, Inc. | -102.06 Million USD | -434.05% |
| Context Therapeutics Inc. | -23.96 Million USD | -2174.483% |
| Exicure, Inc. | -16.91 Million USD | -3122.549% |
| Day One Biopharmaceuticals, Inc. | -188.91 Million USD | -188.519% |
| Oramed Pharmaceuticals Inc. | -37.76 Million USD | -1343.338% |
| Scinai Immunotherapeutics Ltd. | -6.5 Million USD | -8276.131% |
| Rhythm Pharmaceuticals, Inc. | -184.67 Million USD | -195.142% |
| Nuvalent, Inc. | -126.21 Million USD | -331.838% |
| ABVC BioPharma, Inc. | -10.51 Million USD | -5083.338% |
| Carisma Therapeutics, Inc. | -86.87 Million USD | -527.381% |
| Unicycive Therapeutics, Inc. | -30.54 Million USD | -1684.514% |
| OmniAb, Inc. | -50.61 Million USD | -976.793% |
| Anew Medical, Inc. | 1.34 Million USD | 40591.188% |
| Fennec Pharmaceuticals Inc. | -16.04 Million USD | -3297.083% |
| Lipocine Inc. | -16.35 Million USD | -3233.288% |
| Lexeo Therapeutics, Inc. Common Stock | -66.39 Million USD | -720.951% |
| Nautilus Biotechnology, Inc. | -63.67 Million USD | -756.006% |
| SAB Biotherapeutics, Inc. | -42.19 Million USD | -1191.806% |
| G1 Therapeutics, Inc. | -47.96 Million USD | -1036.327% |
| Bellerophon Therapeutics, Inc. | -19.83 Million USD | -2648.535% |
| Sage Therapeutics, Inc. | -541.48 Million USD | -0.66% |
| Ocugen, Inc. | -63.07 Million USD | -764.108% |
| Mind Medicine (MindMed) Inc. | -95.73 Million USD | -469.362% |
| Q32 Bio Inc. | -112.96 Million USD | -382.522% |
| Brainstorm Cell Therapeutics Inc. | -17.19 Million USD | -3070.44% |
| Alumis Inc. Common Stock | -154.99 Million USD | -251.669% |
| Equillium, Inc. | -13.33 Million USD | -3987.454% |
| Kyverna Therapeutics, Inc. | -60.36 Million USD | -802.929% |
| Coya Therapeutics, Inc. | -7.98 Million USD | -6723.65% |
| CNS Pharmaceuticals, Inc. | -18.85 Million USD | -2791.388% |
| Galera Therapeutics, Inc. | -59.08 Million USD | -822.552% |
| Evelo Biosciences, Inc. | -114.52 Million USD | -375.924% |
| Comera Life Sciences Holdings, Inc. | -18.37 Million USD | -2865.847% |
| Dominari Holdings Inc. | -22.88 Million USD | -2282.056% |
| Edesa Biotech, Inc. | -8.37 Million USD | -6408.658% |
| vTv Therapeutics Inc. | -20.25 Million USD | -2591.664% |
| Bio-Techne Corporation | 168.1 Million USD | 424.239% |
| Agios Pharmaceuticals, Inc. | -352.08 Million USD | -54.808% |
| Harmony Biosciences Holdings, Inc. | 128.85 Million USD | 523.011% |
| Prelude Therapeutics Incorporated | -121.83 Million USD | -347.388% |
| Candel Therapeutics, Inc. | -37.93 Million USD | -1336.68% |
| iTeos Therapeutics, Inc. | -112.64 Million USD | -383.889% |
| Nkarta, Inc. | -117.5 Million USD | -363.879% |
| BioCardia, Inc. | -11.57 Million USD | -4610.587% |
| Iterum Therapeutics plc | -38.37 Million USD | -1320.505% |